Med. Pro Praxi 2009; 6(5): 249-253

Pheochromocytoma - clinical aspects

MUDr. Branislav Štrauch, Ph.D, doc. MUDr. Tomáš Zelinka, CSc
3. interní klinika VFN, Centrum pro diagnostiku a léčbu hypertenze, Praha

Pheochromocytomas and functional paragangliomas are catecholamine-producing tumors presenting with various clinical symptoms,

but mostly with headache, sweating, palpitations, and hypertension. Biochemical testing for pheochromocytoma should be performed

not only in symptomatic subjects or in subjects with adrenal incidentaloma but also in subjects with a genetic predisposition for pheochromocytoma

(multiple endocrine neoplasia type 2, von Hippel-Lindau syndrome, neurofibromatosis type 1 and mutations of succinate

dehydrogenase genes). Once a pheochromocytoma is proven, computed tomography, magnetic resonance imaging and functional

imaging with [123I] -metaiodobenzylguanidine may be used for tumor localization. Adequate medical pre-treatment is essential for successful

operation, which is performed in most cases by minimal invasive surgery. After tumor removal, further follow-up is necessary

due to possible recurrence.

Keywords: pheochromocytoma, functional paraganglioma, endocrine hypertension.

Published: December 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Štrauch B, Zelinka T. Pheochromocytoma - clinical aspects. Med. praxi. 2009;6(5):249-253.
Download citation

References

  1. Zelinka T, Eisenhofer G, Pacák K. Pheochromocytoma as a catecholamine producing tumor: Implications for clinical practice. Stress 2007; 10: 195-203. Go to original source... Go to PubMed...
  2. Zelinka T, Widimský J, jr. Endokrinní hypertenze. In: Widimský J (Ed.). Hypertenze. Praha: Triton, 2008: 639-666.
  3. Karagiannis A, Mikhailidis DP, Athyros VG, et al. Pheochromocytoma: an update on genetics and management. Endocr Relat Cancer, 2007; 14: 935-956. Go to original source... Go to PubMed...
  4. Pacák K. Feochromocytom. 1. vyd. Praha: Galén, 2008.
  5. Chrisoulidou A, Kaltsas G, Ilias I, et al. The diagnosis and management of malignant phaeochromocytoma and paraganglioma. Endocr Relat Cancer, 2007; 14: 569-585. Go to original source... Go to PubMed...
  6. Tischler AS. Pheochromocytoma and extra-adrenal paraganglioma: updates. Arch Pathol Lab Med, 2008; 132: 1272-1284. Go to original source...
  7. Ilias I, Chen CC, Carrasquillo JA, et al. Comparison of 6-18Ffluorodopamine PET with 123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma. J Nucl Med, 2008; 49: 1613-1619. Go to original source... Go to PubMed...
  8. Petrášek J. Feochromocytom. Současné možnosti klinické diagnostiky a léčby. 1. vyd. Praha: Avicenum. Zdravotnické nakladatelství, 1976.
  9. Bravo EL, Tagle R. Pheochromocytoma: state-of-the-art and future prospects. Endocrine reviews, 2003; 24: 539-553. Go to original source... Go to PubMed...
  10. Zelinka T, Štrauch B, Petrák O, et al. Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients. J Hypertens, 2005; 23: 2033-2039. Go to original source... Go to PubMed...
  11. Zelinka T, Petrák O, Štrauch B, et al. Elevated inflammation markers in pheochromocytoma compared to other forms of hypertension. Neuroimmunomodulation, 2007; 14: 57-64. Go to original source... Go to PubMed...
  12. Holaj R, Zelinka T, Wichterle D, et al. Increased carotid intima-media thickness in patients with pheochromocytoma in comparison to essential hypertension. J Hum Hypertens, 2009; 23: 350-358. Go to original source... Go to PubMed...
  13. Lenders JW, Pacak K, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA, 2002; 287: 1427-1434. Go to original source... Go to PubMed...
  14. Pacak K, Eisenhofer G, Ahlman H, et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab, 2007; 3: 92-102. Go to original source... Go to PubMed...
  15. Eisenhofer G, Goldstein DS, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: how to distinguish truefrom false-positive test results. J Clin Endocrinol Metab, 2003; 88: 2656-2666. Go to original source... Go to PubMed...
  16. Zelinka T, Timmers HJ, Kozupa A, et al. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: Specific implications for SDHB gene mutations. Endocr Relat Cancer, 2008; 15: 311-323. Go to original source... Go to PubMed...
  17. Brunaud L, Ayav A, Zarnegar R, et al. Prospective evaluation of 100 robotic-assisted unilateral adrenalectomies. Surgery 2008; 144: 995-1001. Go to original source... Go to PubMed...
  18. Študent V, Belej K, Vidlář A, et al. Laparoskopická parciální adrenalektomie u feochromocytomu. Čes Urol, 2001; 5: 28-31.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.